ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE for sarcoma, synovial

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 May 2026: Trial started, NCT07613723
  2. 29 May 2026: Trial registered, NCT07613723

The trials

NCT07613723: A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies

State
Under way
Phase
Phase 1
People
9 planned
Started
11 May 2026
Primary completion
Dec 2028
Arms
ZI-MA4-1 (TCR-NK cells)
Results
None posted
  1. 11 May 2026: Trial started
  2. 29 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.